Development of tumor-targeting aza-vesamicol derivatives with high affinity for sigma receptors for cancer theranostics

unknow

★ 5.0 · 14 reads

Sign in to save this
Request Code
ZLIB.IO18508624
Published
2022
Pages
1
Language
Unknown